Neuroborreliosis and Post-Treatment Lyme Disease Syndrome: Focus on Children.
PTLSD
children
neuroborreliosis
variable major protein-like sequence
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
28 Mar 2023
28 Mar 2023
Historique:
received:
14
02
2023
revised:
22
03
2023
accepted:
26
03
2023
medline:
28
4
2023
pubmed:
28
4
2023
entrez:
28
4
2023
Statut:
epublish
Résumé
Neuroborreliosis is a form of Lyme Borreliosis (LB) that affects various structures of the central and peripheral nervous system. Although most cases of LB can be cured with a course of antibiotics, some children can present prolonged symptoms, which may constitute post-treatment Lyme disease syndrome (PTLDS). The aim of our analysis was the long-term observation of children with NB and the determination of their risk of PTLDS. The clinical observation was supplemented by a laboratory study based on the assessment of the dynamics of anti-VlsE (variable major protein-like sequence, expressed) IgG antibodies in children with NB after antibiotic therapy. The prospective survey based on 40 children presented 1-2 forms of NB. The control group consisted of 36 patients with analogical symptoms for whom LB was excluded. Our long-term observation showed a low risk of developing long-term complications in children who received antibiotic therapy in accordance with the recommendations. The concentration of anti-VlsE IgG demonstrates a statistical significance for differences between the control and the study groups for each measurement period. Higher values of anti-VlsE IgG were observed in the study group, and the concentration decreased from the first measurement period to the next. The article emphasizes the importance of the long-term follow-up of children with neuroborreliosis.
Identifiants
pubmed: 37109429
pii: life13040900
doi: 10.3390/life13040900
pmc: PMC10145507
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Clin Transl Neurol. 2022 Jan;9(1):41-49
pubmed: 35064770
N Engl J Med. 1996 Oct 24;335(17):1270-4
pubmed: 8857006
Eur Neurol. 2003;50(2):109-12
pubmed: 12944718
MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):590-1
pubmed: 7623762
Swiss Med Wkly. 2016 Dec 05;146:w14353
pubmed: 27922168
Eur J Clin Microbiol Infect Dis. 2008 May;27(5):349-54
pubmed: 18197445
Eur J Clin Microbiol Infect Dis. 2001 Jan;20(1):6-13
pubmed: 11245327
Infect Dis Clin North Am. 2015 Jun;29(2):295-307
pubmed: 25999225
Przegl Epidemiol. 2008;62(1):193-9
pubmed: 18536243
Front Med (Lausanne). 2020 Jul 23;7:265
pubmed: 32793606
Parasitol Res. 2022 Mar;121(3):781-803
pubmed: 35122516
Eur J Clin Microbiol Infect Dis. 2021 Nov;40(11):2455-2458
pubmed: 33977412
Can J Infect Dis Med Microbiol. 2018 Oct 24;2018:5719081
pubmed: 30473737
Pediatr Infect Dis J. 2017 Nov;36(11):1052-1056
pubmed: 28654563
Curr Issues Mol Biol. 2021;42:473-518
pubmed: 33353871
Emerg Infect Dis. 2021 Aug;27(8):2017-2024
pubmed: 34286689
Emerg Infect Dis. 2005 Nov;11(11):1794-5
pubmed: 16422006
Ticks Tick Borne Dis. 2021 Sep;12(5):101766
pubmed: 34161868
Ann Agric Environ Med. 2021 Jun 14;28(2):277-282
pubmed: 34184511
Pediatr Infect Dis J. 2021 Nov 1;40(11):e442-e444
pubmed: 34636801
Med Pr. 2016;67(1):73-87
pubmed: 27044720
Life (Basel). 2022 Dec 27;13(1):
pubmed: 36676022
Brain Sci. 2021 Jun 07;11(6):
pubmed: 34200467
Scand J Infect Dis. 2009;41(2):88-94
pubmed: 19065451
IDCases. 2018 Dec 29;15:e00479
pubmed: 30622896
Int J Pediatr Otorhinolaryngol. 2020 May;132:109905
pubmed: 32035348
Pediatr Infect Dis J. 1998 Mar;17(3):189-96
pubmed: 9535244
Otol Neurotol. 2004 Sep;25(5):838-41
pubmed: 15354020
Cureus. 2021 Oct 12;13(10):e18703
pubmed: 34659931
Infect Dis (Lond). 2015 Jan;47(1):1-6
pubmed: 25342573
Clin Vaccine Immunol. 2008 Dec;15(12):1796-804
pubmed: 18945880
Science. 1982 Jun 18;216(4552):1317-9
pubmed: 7043737